• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Solution reagent kit IDNAPTEX
for researchfor PCRclinical

Solution reagent kit - IDNAPTEX - ID SOLUTIONS Oncology SAS - for research / for PCR / clinical
Solution reagent kit - IDNAPTEX - ID SOLUTIONS Oncology SAS - for research / for PCR / clinical
Add to favorites
Compare this product
 

Characteristics

Type
solution
Applications
clinical, for research, for PCR, FFPE tissues
Format
liquid

Description

Enabling the simultaneous detection of mutations in ctDNA and gDNA for research applications on liquid biopsy and FFPE SIMPLE Ready-to-use Primers and Probes Mix; Up to 42 targets in a single reaction picto-rapide FAST DNA-to-result in less than 3 hours picto-controle RELIABLE Target controls included ACCURATE Patented technology* included logo-comptabilite OPTIMIZED Universal amplification program for all assays on QIAcuity 5Plex digital PCR system Cutting-Edge Multiplexed Technology IDNAPTEX products detect mutations in DNA from plasma (cfDNA) or FFPE tissue (gDNA) for your oncology research. Our assays are designed with an optimized ready-to-use primers and probes, enabling the simultaneous amplification of multiple targeted mutations in a single well. Universal Amplification Program compatible for all assays When combined with the QIAcuity 5Plex digital PCR system, IDNAPTEX delivers results in less than three hours—providing a fast, reliable, and high-performance solution for clinical oncology research.​ Accurate detection of mutations Optimized for ease of use and result reproducibility, the reagents include a Target Process Control (TPC) for enhanced accuracy. The patented using ID-ICE reagent enables optimal monitoring of the entire pre-analytical process, reinforcing the reliability of the results obtained.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.